BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 06, 2010
 |  BC Week In Review  |  Company News  |  Deals

OncoMethylome, Roche deal

OncoMethylome will use its Methylation-Specific PCR technology to provide testing services to detect methylation of the O-6-methylguanine DNA methyltransferase ( MGMT) gene promoter in a Phase III trial for Roche's Avastin bevacizumab in...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >